Meet with Crystec at Drug Delivery to the Lungs conference (DDL), Edinburgh, 12th - 14th December 2018
Crystec are attending Edinburgh’s annual conference focused on working to advance respiratory science.
Crystec will be at Drug Delivery to the Lungs conference (DDL) in Edinburgh, from 12th - 14th December. Contact us to schedule a meeting at the event, to learn more about how our modified Supercritical Anti-Solvent (mSAS) technology can be applied to optimise the delivery of inhalation products.
Catherine Hunter, Business Development Director, will be at the meeting, which takes place in Edinburgh each year and focuses on the development of medicines for inhalation.
Please contact Emily Bevis (email@example.com) to schedule a meeting or for more information about how Crystec’s technology can contribute to your inhalation programmes.
For more information about DDL, visit https://aerosol-soc.com/events/ddl2018/.